TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Mutations in the TP53 tumor suppressor gene are common in human cancers.
• The functional impact of specific TP53 mutations, like H179, is not fully understood.
• Understanding these mutations is crucial for cancer treatment strategies.

Purpose of the Study:

• To investigate the functional consequences of TP53 H179 mutations in cancer.
• To determine if TP53 H179 mutations are associated with patient survival outcomes.
• To explore the molecular mechanisms by which these mutants promote tumor progression.

Main Methods:

• Pan-cancer database analysis to correlate TP53 H179 mutations with survival.
• Functional studies using cancer cell lines (lung, ovarian, prostate) over-expressing p53 H179 mutants.
• Analysis of metabolic reprogramming, lipid synthesis, lipid droplet accumulation, and APOE expression.

Main Results:

• TP53 H179 mutations are linked to poorer disease-free survival across various cancer types.
• p53 H179 mutants are defective in tumor suppression and actively promote tumor progression.
• Mutants induce metabolic reprogramming, increasing neutral lipid levels via fatty acid synthesis/uptake, and upregulate APOE, enhancing invasiveness.

Conclusions:

• TP53 missense mutations are not functionally equivalent to TP53 loss.
• TP53 H179 mutations function as oncogenic drivers.
• APOE and lipid metabolism represent potential therapeutic targets for cancers harboring these specific TP53 mutations.